The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension
HL Kim, EM Lee, SY Ahn, K Kim, HC Kim, JH Kim… - Clinical …, 2023 - Springer
Hypertension is the leading cause of death in human being, which shows high prevalence
and associated complications that increase the mortality and morbidity. Controlling blood …
and associated complications that increase the mortality and morbidity. Controlling blood …
The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low-and middle-income countries—a review of the current …
Chronic kidney disease (CKD) in people with diabetes is becoming an increasing major
public health concern, disproportionately burdening low-and middle-income countries …
public health concern, disproportionately burdening low-and middle-income countries …
Chronic kidney disease in low-income to middle-income countries: the case for increased screening
C George, A Mogueo, I Okpechi… - BMJ global …, 2017 - gh.bmj.com
Chronic kidney disease (CKD) is fast becoming a major public health issue,
disproportionately burdening low-income to middle-income countries, where detection rates …
disproportionately burdening low-income to middle-income countries, where detection rates …
Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement
DW Johnson, GRD Jones, TH Mathew… - Medical Journal of …, 2012 - Wiley Online Library
Optimal detection and subsequent risk stratification of people with chronic kidney disease
(CKD) requires simultaneous consideration of both kidney function (glomerular filtration rate …
(CKD) requires simultaneous consideration of both kidney function (glomerular filtration rate …
Doxycycline combined with bortezomib-cyclophosphamide-dexamethasone chemotherapy for newly diagnosed cardiac light-chain amyloidosis: a multicenter …
K Shen, W Fu, Y Wu, Y Dong, Z Huang, Y Wei, C Li… - Circulation, 2022 - Am Heart Assoc
Background: Doxycycline was demonstrated in a retrospective study to be associated with
greater survival in patients with light chain amyloidosis. Therefore, we prospectively …
greater survival in patients with light chain amyloidosis. Therefore, we prospectively …
Effect of a 3-year lifestyle intervention in patients with chronic kidney disease: a randomized clinical trial
KS Beetham, R Krishnasamy, T Stanton… - Journal of the …, 2022 - journals.lww.com
Background Supervised lifestyle interventions have the potential to significantly improve
physical activity and fitness in patients with CKD. Methods To assess the efficacy of a …
physical activity and fitness in patients with CKD. Methods To assess the efficacy of a …
Quality of chronic kidney disease management in Canadian primary care
Importance Although patients with chronic kidney disease (CKD) are routinely managed in
primary care settings, no nationally representative study has assessed the quality of care …
primary care settings, no nationally representative study has assessed the quality of care …
[HTML][HTML] Uncertainty in measurement: a review of Monte Carlo simulation using Microsoft Excel for the calculation of uncertainties through functional relationships …
I Farrance, R Frenkel - The Clinical Biochemist Reviews, 2014 - ncbi.nlm.nih.gov
Abstract The Guide to the Expression of Uncertainty in Measurement (usually referred to as
the GUM) provides the basic framework for evaluating uncertainty in measurement. The …
the GUM) provides the basic framework for evaluating uncertainty in measurement. The …
Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project
H Htay, M Alrukhaimi, GE Ashuntantang… - Kidney international …, 2018 - Elsevier
Access to essential medications and health products is critical to effective management of
kidney disease. Using data from the ISN Global Kidney Health Atlas multinational cross …
kidney disease. Using data from the ISN Global Kidney Health Atlas multinational cross …
Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: a systematic review for the development of recommendations to reduce …
Background Metformin is usually prescribed as first line therapy for type 2 diabetes mellitus
(DM2). However, the benefits and risks of metformin may be different for older people. This …
(DM2). However, the benefits and risks of metformin may be different for older people. This …